Half-year report · HY
4360.TEDINET S100WWZT
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥452m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | −¥212m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥503m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥275m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥195m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥588m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥195m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥465m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥895m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥137m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥465m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥137m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥14.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥12.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥13.7bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.6bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥2.3bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.1bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.5bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥991m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥108m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥94m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥678m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥489m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥171m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥450m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥126m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥62m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥57.27 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-110.77 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.05 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 75.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Fine Chemical Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.9bn |
| Fine Chemical Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.9bn |
| Fine Chemical Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥701m |
| Flame Retardants Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Flame Retardants Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Flame Retardants Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥239m |
| Health Support Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥714m |
| Health Support Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥714m |
| Health Support Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥61m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥5.8bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥5.8bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥1.0bn |
| Fine Chemical Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Fine Chemical Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Fine Chemical Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥301m |
| Flame Retardants Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| Flame Retardants Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| Flame Retardants Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2m |
| Health Support Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥673m |
| Health Support Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥673m |
| Health Support Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥26m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥330m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 450
| Item | Context | Value | Unit |
|---|---|---|---|
| Directors compensations sga | Prior1InterimDuration | 77000000 | JPY |
| Directors compensations sga | InterimDuration | 91000000 | JPY |
| Salaries and bonuses sga | Prior1InterimDuration | 223000000 | JPY |
| Salaries and bonuses sga | InterimDuration | 198000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 50000000 | JPY |
| Provision for bonuses sga | InterimDuration | 37000000 | JPY |
| Defined contribution pension plan premium | Prior1InterimDuration | 8000000 | JPY |
| Defined contribution pension plan premium | InterimDuration | 8000000 | JPY |
| Haulage expenses sga | Prior1InterimDuration | 79000000 | JPY |
| Haulage expenses sga | InterimDuration | 91000000 | JPY |
| Commission fee sga | Prior1InterimDuration | 85000000 | JPY |
| Commission fee sga | InterimDuration | 100000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E36769-000FineChemicalBusinessReportableSegmentsMember | 1834000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 1986000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E36769-000HealthSupportBusinessReportableSegmentsMember | 673000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 4494000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E36769-000FineChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E36769-000HealthSupportBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E36769-000FineChemicalBusinessReportableSegmentsMember | 1834000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 1986000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E36769-000HealthSupportBusinessReportableSegmentsMember | 673000000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 4494000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E36769-000FineChemicalBusinessReportableSegmentsMember | 301000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 2000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E36769-000HealthSupportBusinessReportableSegmentsMember | 26000000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 330000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E36769-000FineChemicalBusinessReportableSegmentsMember | 2857000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 2232000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E36769-000HealthSupportBusinessReportableSegmentsMember | 714000000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 5804000000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E36769-000FineChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E36769-000HealthSupportBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_ReportableSegmentsMember | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E36769-000FineChemicalBusinessReportableSegmentsMember | 2857000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 2232000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E36769-000HealthSupportBusinessReportableSegmentsMember | 714000000 | JPY |
| Net sales | InterimDuration_ReportableSegmentsMember | 5804000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E36769-000FineChemicalBusinessReportableSegmentsMember | 701000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 239000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E36769-000HealthSupportBusinessReportableSegmentsMember | 61000000 | JPY |
| Operating income | InterimDuration_ReportableSegmentsMember | 1002000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-14 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第５期中（自 2025年４月１日 至 2025年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社マナック・ケミカル・パートナーズ |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |